Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D0NI0X
|
||||
| Former ID |
DIB011820
|
||||
| Drug Name |
SCH-721015
|
||||
| Synonyms |
RAd-IFN, Merck & Co; RAd-IFN, Schering-Plough; Ad.hIFN-alpha2b, Merck & Co; Recombinant adenovirus vector expressing hybrid-interferon (bladder neoplasm), Merck & Co
|
||||
| Indication | Mesothelioma [ICD9: 163; ICD10:C45] | Phase 1 | [523112] | ||
| Company |
Fkd therapies
|
||||
| Target and Pathway | |||||
| Target(s) | Interferon alpha 2 ligand | Target Info | Modulator | [531615] | |
| KEGG Pathway | Cytokine-cytokine receptor interaction | ||||
| Regulation of autophagy | |||||
| PI3K-Akt signaling pathway | |||||
| Toll-like receptor signaling pathway | |||||
| RIG-I-like receptor signaling pathway | |||||
| Cytosolic DNA-sensing pathway | |||||
| Jak-STAT signaling pathway | |||||
| Natural killer cell mediated cytotoxicity | |||||
| Tuberculosis | |||||
| Hepatitis C | |||||
| Hepatitis B | |||||
| Measles | |||||
| Influenza A | |||||
| Herpes simplex infection | |||||
| Autoimmune thyroid disease | |||||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| Pathway Interaction Database | Downstream signaling in naï | ||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.